Palisade Bio Reports Q2 2026 Financial Results

What Happened
Palisade Bio, Inc. (PALI) announced its financial results for the three and six months ended June 30, 2026 in a press release issued August 10, 2026. The company filed Form 8-K (Item 2.02) to disclose the results and attached the press release as Exhibit 99.1.

Key Details

• Filing date: August 10, 2026 (Form 8-K).
• Reporting period: three and six months ended June 30, 2026.
• Press release attached as Exhibit 99.1 and incorporated by reference.
• Form signed by CEO J.D. Finley; interactive XBRL cover page included as Exhibit 104.

Why It Matters
The 8-K signals that Palisade has published its quarterly financial and operating results; investors should review the attached press release (Exhibit 99.1) for specifics on revenue, net income/loss, cash position, and any management commentary or guidance. This disclosure is the company’s official update for quarterly performance and can affect valuation, trading, and investor decisions once the detailed figures are reviewed.